Fortress Biotech, Inc. - 31 Mar 2023 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
10%+ Owner
Signature
/s/ Samuel Berry, General Counsel and Authorized Agent
Issuer symbol
CKPT
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 16:06:49 UTC
Previous filing
06 Jan 2023
Next filing
03 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK, PAR VALUE $0.0001 Award $0 +35,714 +2.4% $0.000000 1,539,427 31 Mar 2023 Direct F1
transaction CKPT COMMON STOCK, PAR VALUE $0.0001 Award $0 +42,500 +2.8% $0.000000 1,581,927 04 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. These shares were granted by the Issuer to the Reporting Person following the closing of a financing.